A. Risitano
833  Ergebnisse:
Personensuche X
?
1

OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FO..:

Fonseca, AR ; Justino, CC ; Molla, VC...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S17 , 2023
 
?
2

L'inhibiteur oral du facteur b du complément iptacopan chez..:

Peffault De Latour, R. ; Roth, A. ; Soret, J....
La Revue de Médecine Interne.  43 (2022)  - p. A355-A356 , 2022
 
?
6

RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATI..:

Weitz, H. ; Hillmen, P. ; Szer, J....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 12-13 , 2020
 
?
7

Network levels and Public health potential: the case –study..:

Risitano, A ; Raia, M ; Castrianni, D...
European Journal of Public Health.  27 (2017)  suppl_3 - p. , 2017
 
?
8

Determination of critical stress in high strength concrete:

D'Aveni, A. ; Fargione, G. ; Gugliemino, E...
Procedia Structural Integrity.  3 (2017)  - p. 432-440 , 2017
 
?
9

Identification of local phenomena of plasticity in concrete..:

Risitano, A ; D'Aveni, A. ; Fargione, G..
Procedia Structural Integrity.  2 (2016)  - p. 2123-2131 , 2016
 
?
11

Determining fatigue limits with thermal analysis of static ..:

Risitano, A. ; Risitano, G.
Fatigue & Fracture of Engineering Materials & Structures.  36 (2013)  7 - p. 631-639 , 2013
 
?
 
?
 
?
15

Cumulative damage evaluation of steel using infrared thermo..:

Risitano, A. ; Risitano, G.
Theoretical and Applied Fracture Mechanics.  54 (2010)  2 - p. 82-90 , 2010
 
1-15